Originally published June 2016. Updated June 2026.
The most consequential corporate communications transition in American aquaculture in the last decade is the one almost nobody covered. In December 2017, Cooke Inc., the privately held New Brunswick seafood conglomerate run by the Cooke family, closed its acquisition of Omega Protein Corporation for approximately $500 million. Omega Protein, the largest menhaden harvester in the United States, was at the time a Houston-based NYSE-listed company (OME) with operations across the Gulf of Mexico and the Atlantic, a controversial regulatory profile, and an investor-relations function carrying years of activist pressure.
The acquisition closed and the press cycle ended. Omega Protein delisted from the New York Stock Exchange. The reduction-fishery business that had been the subject of repeated environmental campaigns from the Chesapeake Bay Foundation, the Theodore Roosevelt Conservation Partnership, and the Atlantic States Marine Fisheries Commission went private — and went quiet. The communications shift is the story.
What Omega Protein actually does
Omega Protein is a reduction fishery. It harvests menhaden — small, oily, schooling fish that biologist H. Bruce Franklin called "the most important fish in the sea" — and processes them into fishmeal, fish oil, and omega-3 nutritional concentrates. The fishmeal feeds aquaculture and livestock. The fish oil feeds the consumer supplements market. The omega-3 concentrates feed pharmaceutical and infant-formula supply chains. The company harvests an estimated 70-plus percent of the Atlantic menhaden catch in any given year.
The communications problem is structural. Menhaden are filter feeders that anchor the Chesapeake Bay ecosystem; they are bait fish for striped bass, ospreys, and dozens of commercially fished species; and they reproduce on cycles that do not align with the catch-cap politics of the Atlantic States Marine Fisheries Commission. Every year Omega Protein operates in the Chesapeake Bay reduction fishery, it operates inside a live PR theater with environmental groups, recreational-fishing lobbies, Virginia state legislators, and federal regulators.
The pre-acquisition crisis arc
Through the 2010s, Omega Protein was a publicly traded company with an activist-investor problem on one side and an environmental-coalition problem on the other. The 2016 dissident shareholder action by Wynnefield Capital Management — a lawsuit filed in Nevada state court demanding shareholder lists and a stay of the company's annual meeting — was an early IR communications stress test. The company called the action "frivolous" and committed to defending it. Wynnefield held roughly 7.9% of the outstanding shares and was pushing for the election of Michael Christodolou as director over the incumbent Gary Ermers, citing a Human Nutrition business problem the activist framed as a governance failure.
In parallel the company was running a continuous regulatory communications campaign on its menhaden quotas — Atlantic harvest caps, Chesapeake Bay reduction fishery limits, and the recurring public hearings of the ASMFC Menhaden Management Board. The communications surface was wide, the messaging was reactive, and the brand carried more public liability than any of its actual product categories deserved.
What changed when Cooke acquired it
Cooke Inc. is privately held, family-controlled, and structurally protected from quarterly earnings calls, dissident shareholder filings, and the IR communications cadence that comes with a NYSE listing. The acquisition delisted Omega Protein from public-market reporting and folded it into Cooke's portfolio alongside True North Seafood, Cooke Aquaculture, Wanchese Fish Company, and the company's other holdings. Three communications consequences followed.
The activist-investor surface disappeared. Once Omega Protein delisted, the structural pathway for activist communications campaigns against the company's governance closed. Wynnefield-pattern actions against a privately held subsidiary are not legally available in the same form. The communications drag from quarterly IR became zero overnight.
The environmental-regulatory surface remained — and quieted. Menhaden quotas, ASMFC hearings, Chesapeake Bay coalition pressure, and Virginia state legislative debates over reduction-fishery quotas all continued. What changed was the communications response. Omega Protein under Cooke runs a narrower public-facing communications operation: less proactive media work, fewer corporate-narrative campaigns, more straight regulatory communications and trade-press engagement. The conflict did not end. It just stopped being a brand-management problem and became a regulatory-affairs problem.
The ESG and supply-chain communications surface expanded. Cooke has built a portfolio communications strategy around sustainability certification, traceability, and aquaculture-feed responsibility that absorbs Omega Protein's reduction-fishery output into a larger, defended narrative. The brand surface is no longer "Omega Protein, the menhaden harvester." It is "Cooke, the integrated seafood company, of which menhaden reduction is one upstream input." The communications repositioning is structural, and it has held.
The communications takeaway for B2B brands carrying activist pressure
The Omega Protein case is the cleanest available example of what going private actually does to a communications problem. Three lessons:
- Public-market disclosure compounds the activist communications surface. Every quarterly call, every proxy filing, every 10-K is a new attack surface. The companies carrying genuine activist exposure are over-disclosing into the problem and under-positioning into the solution.
- Going private does not end a controversy — it changes which counterparty owns the communications relationship. The menhaden controversy did not stop in December 2017. It just stopped being a brand story and started being a regulatory-affairs story. Different vocabulary. Different press cadence. Different reputation surface.
- Portfolio absorption is a viable communications strategy for high-friction subsidiaries. Cooke's repositioning of Omega Protein inside an integrated seafood-and-aquaculture narrative diluted the brand-attack surface without changing the underlying operation. The communications dividend was the quiet.
FAQ
Who owns Omega Protein?
Cooke Inc., the privately held New Brunswick, Canada-based seafood and aquaculture conglomerate, has owned Omega Protein since December 2017 following a tender offer valuing the company at approximately $500 million.
What does Omega Protein produce?
Omega Protein operates a reduction fishery harvesting Atlantic and Gulf menhaden, processing them into fishmeal, fish oil, and omega-3 nutritional concentrates. The company supplies aquaculture feed markets, the consumer omega-3 supplements market, and pharmaceutical-grade omega-3 supply chains.
Why is Omega Protein controversial?
Atlantic menhaden are a structurally important forage-fish species. Environmental groups including the Chesapeake Bay Foundation and the Theodore Roosevelt Conservation Partnership have long argued that reduction-fishery harvesting at scale undermines striped bass populations, osprey nesting, and the broader Chesapeake Bay ecosystem. The Atlantic States Marine Fisheries Commission regulates the harvest.
Is Omega Protein still publicly traded?
No. Omega Protein delisted from the New York Stock Exchange following the December 2017 Cooke acquisition and now operates as a privately held subsidiary.
What was the Wynnefield Capital lawsuit?
In 2016, Wynnefield Capital Management filed a Nevada state-court action as a dissident shareholder seeking access to Omega Protein's shareholder list and a stay of the company's annual meeting. The company called the action frivolous and continued to operate through the proxy contest until the Cooke acquisition resolved the governance question by taking the company private.
What is the communications takeaway from the Cooke acquisition?
Going private removes the activist-investor communications surface and shifts the controversy from a brand-management problem to a regulatory-affairs problem. Portfolio absorption inside an integrated parent narrative — in this case Cooke's broader seafood-and-aquaculture positioning — dilutes the brand-attack surface without changing the underlying operation.
Related EPR Coverage: Food & Beverage · Corporate Communications · Investor Relations
By the EPR Editorial Team
